Elixirgen Scientific
Business Services · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
855 N Wolfe St Ste 631, Baltimore, Maryl...Website
www.elixirgensci.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Elixirgen Scientific
Elixirgen Scientific specializes in induced pluripotent stem cell (iPSC) technology, offering products and services that facilitate drug discovery and disease modeling. Their extensive range of iPSC-derived cells includes various neuron types, astrocytes, and differentiation kits designed to accelerate research. They provide tailored services such as custom iPSC differentiation and novel cell type development to meet unique research needs. Target clients include researchers and organizations involved in biomedical research and drug development.Explore more
Elixirgen Scientific Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Elixirgen Scientific your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Elixirgen Scientific has new funding data
Click to see if Elixirgen Scientific had a recent Job posting/layoffs
Check out if Elixirgen Scientific is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Elixirgen Scientific
Earning: See what the market has to say on Elixirgen Scientific recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Elixirgen Scientific, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Elixirgen Scientific launches new products
Website visits: Recent activity has been detected on your website
Check if Elixirgen Scientific has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Elixirgen Scientific
Compare insights from companies similar to Elixirgen Scientific, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Elixirgen Scientific is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Elixirgen Scientific is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Elixirgen Scientific.
Elixirgen Scientific Tech Stack
A closer look at the technologies used by Elixirgen Scientific
Most Recent Scoops
Open Position
Open Position
Open Position
New Hire
Executive Move
Elixirgen Scientific News & Media
Elixirgen Therapeutics planning to begin Phase I/II Clinical Trials of its COVID-19 Vaccine Candidate EXG-5003 at Fujita Health University
BALTIMORE, Sept. 1, 2020 /PRNewswire/ -- Elixirgen Therapeutics, Inc., a Baltimore-based biotechnology company focused on the discovery, development and commercialization of therapies for genetic diseases and vaccines, announced that Fujita Health University has received a contract from...Elixirgen Therapeutics Concludes pre-IND Meeting with FDA for its COVID-19 Vaccine Candidate EXG-5003
BALTIMORE, June 4, 2020 /PRNewswire/ -- Elixirgen Therapeutics, Inc., a Baltimore-based biotechnology company focused on the discovery, development, and commercialization of therapies for genetic diseases and vaccines, announced that it concluded on May 18 its pre-Investigational New Drug...FDA Approves Elixirgen Therapeutics IND Application for Therapy for Telomere Biology Disorders with Bone Marrow Failure
Elixirgen Therapeutics, Inc., a Baltimore-based biotechnology company focused on the discovery, development, and commercialization of therapies for genetic diseases and vaccines, received confirmation from the U.S. Food and Drug Administration (FDA) that its Investigational New Drug (IND) application for its lead candidate, EXG34217, was approved on May 23, 2020. EXG34217 is an autologous cell therapy for telomere biology disorders with bone marrow failure.Ricoh Announces Strategic Business Partnership with Elixirgen Scientific
TOKYO, June 19, 2019 /PRNewswire/ -- Ricoh Company, Ltd., (Tokyo, Japan) today announced it has entered into a strategic business partnership with Elixirgen Scientific, Inc., (Baltimore, Maryland, USA), to develop innovative biomedical products and services that support drug discovery...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Elixirgen Scientific
Sign Up For FreeTo access detailed company insights
Elixirgen Scientific specializes in induced pluripotent stem cell (iPSC) technology, offering products and services that facilitate drug discovery and disease modeling. Their extensive range of iPSC-derived cells includes various neuron types, astrocytes, and differentiation kits designed to accelerate research. They provide tailored services such... Read More
